Gynecologic Oncology Clinical Trials

Central to the department’s mission of providing exceptional
research-driven care is the development of clinical research trials,
including prevention trials, innovative surgical trials and therapeutic
trials. The following is a list of ongoing major therapeutic trials.

Central to the department’s mission of providing exceptional
research-driven care is the development of clinical research trials,
including prevention trials, innovative surgical trials and therapeutic
trials. The following is a list of ongoing major therapeutic trials.

All solid tumor sites

2015-0035 (COTI-2): A phase I study of COTI-2 for the treatment of advanced or recurrent gynecologic malignancies

2016-1129 (selumetinib + olaparib): Evaluation of the combination of selumetinib and olaparib in endometrial, ovarian and other solid tumors with Ras pathway alterations, and ovarian tumors with PARP resistance